[ Clinicians Main Page ] [ V Book Sidebars ] [ V Book Endnotes ] [ Recent Journal References ]

Complete Endnotes from The V Book

[ Chapters 1-4 ] [ Chapters 5-7 ] [ Chapters 8-10 ] [ Chapters 11-13 ]
[ Chapters 14-15 ] [ Chapters 16-17 ] [ Chapters 18-19 ] [ Chapters 20-22 ]

Key To Journal Abbreviations

If you're interested in doing further research, the following is a list of medical journals I have cited in this text along with their abbreviations for easy reference. Some of these journals can be accessed for free online at the websites I've provided below (others require a paid subscription).

Chapter 14: Could You Be Allergic?

  1. J. V. Bosso, M. J. Aiken, R. A. Simon, Successful prevention of local and cutaneous hypersensitivity reactions to seminal fluid with intravaginal cromolyn, Allergy Proc 1991:12(2):113–16.
  2. I. L. Bernstein, B. E. Englander, J. S. Gallagher, P. Nathan, et al., Localized and systemic hypersensitivity reactions to human seminal fluid, Ann Int Med 1981:94(1):459–65; S. A. Friedman, I. L. Bernstein, M. Enrione, Z. H. Marcus, Successful long-term immunotherapy for human seminal plasma anaphylaxis, JAMA 1984:251(20):2684–87.
  3. W. R. Jones, Allergy to coitus, Aust NZ J Obstet Gynaecol 1991:31:137–41.
  4. J. A. Bernstein, R. Sugumaran, D. I. Bernstein, I. L. Bernstein, Prevalence of human seminal plasma hypersensitivity among symptomatic women, Ann Allergy 1997:78:54–58.
  5. Jones, Allergy to coitus.
  6. Ibid.
  7. Ibid.
  8. M. H. Goldenhersh, A. Saxon, Seminal fluid hypersensitivity (SFH): a new approach (abstract), Ann Allergy 1989:6:256.
  9. B. N. Halpern, T. Ky, B. Robert, Clinical and immunological study of exceptional case of reaginic type sensitization to human seminal fluid, Immunology 1967:12:247; S. M. Matloff, Local intravaginal desensitization to seminal fluid, J Allergy Clin Immunol 1993:91:1230–31; Bernstein et al., Prevalence of human seminal plasma hypersensitivity.
  10. M. B. Sell, Sensitisation to thioridazine through sexual intercourse, Am J Psych 1985:142:271–72; W. J. Paladine, T. J. Cunningham, M. A. Donovan, Possible sensitivity to vinblastine in prostatic or seminal fluid, N Engl J Med 1975:29:52; R. L. Green, M. H. Green, Postcoital urticaria in a penicillin-sensitive patient, JAMA Assoc 1985:254:531; Z. H. Haddad, Food allergens, Persp Allergy 1978:1:2–3.
  11. B. H. Berman, Seasonal allergic vulvovaginitis caused by pollen, Ann Allergy 1964:22:594–97.
  12. S. S. Witkin, J. Jeremias, Q. J. Ledger, A localized vaginal allergic response in women with recurrent vaginitis, J Allerg Clin Immunol 1989:81:412–16.
  13. A. Nel, C. Gujuluva, Latex antigens: identification and use in clinical and experimental studies, including crossreactivity with food and pollen allergens, Ann Allergy 1998:81:388–98.
  14. C. Perniciaro, S. Alberto, J. Busamante, M. Gutierrez, Two cases of vulvodynia with unusual causes, Acta Derm Venereol (Stockholm) 1993:73:227–28.

Chapter 15: When Skin Gets Sick

  1. P. J. Lynch, Dermatology (Baltimore: Williams & Wilkins, 1994), 305.
  2. P. Marren, F. Wojnarowska, Allergic contact dermatitis and vulvar dermatoses, Br J Dermatol 1992:126:52.
  3. Marren, Br J Dermatol.
  4. Lynch, Dermatology, 46.
  5. C. M. Ridley, Lichen sclerosus: a review, Eur J Dermatol 1994:4:99.
  6. C. M. Ridley, S. M. Neill, Non-infective cutaneous conditions of the vulva, in The Vulva, C. M. Ridley, S. M. Neill, eds. (Oxford, England: Blackwell Science, 1999),157.
  7. R. H. Meyrick-Thomas, C. M. Ridley, D. H. McGibbon, et al., Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women, Br J Dermatol 1988:108:41.
  8. Ridley, Lichen sclerosus: a review.
  9. R. C. D. Staughton, E. B. Lane, et al., The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus, Br J Dermatol 1990:123(suppl 37):62; S. H. Tan, E. Derrick, P. H. McKee, et al., Altered p53 expression and epidermal proliferation is seen in vulval lichen sclerosus, J Cutan Path 1994:21:316; Y. Soini, P. Paako, K. Vahkangas, S. Vuopala, V. P. Lehto, Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features, Int J Gyn Path 1994:13:199.
  10. P. Carli, A. Cattaneo, N. Pimpinelli, et al., Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus and atrophicus, Dermatologica 1991:182:18; P. M. Marren, P. R. Millard, F. Wojnarowska, Vulval lichen sclerosus: lack of correlation between duration of clinical symptoms and histological appearances, J Eur Acad Dermatol Vener 1997:8:212.
  11. K. I. Dalziel, P. R. Millard, F. Wojnarowska, The treatment of vulvar lichen sclerosus with a very potent topical steroid, Br J Derm 1991:124:461.
  12. K. I. Dalziel, F. Wojnarowska, Long term control of vulvar lichen sclerosus after treatment with a potent topical steroid cream, J Repro Med 1993:38:25.
  13. G. L. Bracco, P. Carli, L. Sonni, et al., Clinical and histologic effects of topical treatments of vulvar lichen sclerosus, J Repro Med 1993:38:37.
  14. J. J. Powell, F. Wojnarowska, Lichen sclerosus, Lancet 1999:22(353):9166.
  15. Ridley, Neill, Non-infective cutaneous conditions of the vulva.
  16. M. Sideri, M. Origoni, L. Spinaci, A. Ferrari, Topical testosterone in the treatment of vulvar lichen sclerosus, Int J Gynecol Obstet 1994:46:53.
  17. M. T. Bousema, U. Romppanen, J. M. Geiger, et al., Acitretinin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind placebo controlled study, J Am Acad Dermatol 1994:30:225.
  18. A. Virgili, M. Corazzo, A. Bianchi, et al., Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus, J Reprod Med 1995:40:614.
  19. M. Kartamaa, S. Reitamo, Treatment of lichen sclerosus with carbon dioxide laser vaporization, Br J Dermatol 1997:135:356.
  20. M. McKay, Vulvar dermatoses, Clin Obstet Gynecol 1991:34:614.
  21. S. Zellis, S. H. Pincus, Treatment of vulvar dermatoses, Sem Dermatol 1996:15(1):71.
  22. Ridley, Neill, Non-infective cutaneous conditions of the vulva.
  23. E. M. De Jong, The course of psoriasis, Clin Dermatol 1997:15:687.
  24. M. D. Zanolli, Psoriasis and Reiter’s syndrome, in Principles and Practice of Dermatology, 2nd ed., W. W. Sams, P. J. Lynch, eds. (New York: Churchill Livingstone, 1996).
  25. N. Han, P. Nowakowski, D. West, Common skin disorders: acne and psoriasis, in Pharmacotherapy: A Pathophysiologic Approach, J. DiPiro, R. L. Talbert, G. C. Yee, et al., eds. (Stamford, Conn.: Appleton & Lange, 1999), 1489.
  26. E. Bardolph, R. Ashton, Psoriasis: a review of present and future management, Nurs Stand 1998:12:43.
  27. H. Tagami, Triggering factors, Clin Dermatol 1997:15:677.
  28. J. P. Ortonne, Aetiology and pathogenesis of psoriasis, Br J Dermatol 1996:135(suppl 49):1.
  29. B. P. Peters, F. G. Weissman, M. A. Gill, Pathophysiology and treatment of psoriasis, Am J Health-Syst Pharm 2000:57(7):645.
  30. Ibid.
  31. J. P. Ortonne, Aetiology and pathogenesis of psoriasis, Br J Dermatol 1996:135(suppl 49):1.
  32. B. J. Nickoloff, The immunologic and genetic basis of psoriasis, Arch Dermatol 1999:135:1104.
  33. K. Kragballe, B. T. Gjertsen, D. D. Hoop, et al., Double-blind right/left comparison of calcipotriol and betamethasone 17-valerate in patients with psoriasis vulgaris, Lancet 1991:337:193.
  34. G. S. Drew, Psoriasis, Primary Care 2000:27(2):385; European FK506 Multicenter Psoriasis Study Group, Systemic tacrolimus (FK506) is effective for treatment of psoriasis in a double-blind, placebo-controlled study, Arch Dermatol 1996:132:419.
  35. C. Scully, M. el-Kom, Lichen planus: review and update on pathogenesis, J Oral Pathol 1985:14:431.
  36. G. O. Fischer, The commonest causes of symptomatic vulvar disease: a dermatologist’s perspective, Australas J Dermatol 1996:37:12.
  37. F. M. Lewis, M. Shah, C. I. Harrington, Vulval involvement in lichen planus: a study of 37 women. Br J Dermatol 1996:135:89.
  38. R. S.-H. Tan, P. D. Samman, Ulcerative colitis, myasthenia gravis, atypical lichen planus and vitiligo, Proc Roy Soc Med 1974:67:196; R. S.-H. Tan, P. D. Samman, Thymoma, acquired hypogammaglobulinaemia, lichen planus and alopecia areata, Proc Roy Soc Med 1974:67:196.
  39. S. M. Neill, Erosive lichen planus: diagnosis and management (syllabus of the postgraduate course), International Society for the Study of Vulvovaginal Disease, October 1999.
  40. C. M. Ridley, Chronic erosive vulval disease, Clin Exp Dermatol 1990:15:245.
  41. F. M. Lewis, Vulval lichen planus, Br J Dermatol 1998:138:569.
  42. M. Pelisse, Erosive vulvar lichen planus and desquamative vaginitis, Semin Dermatol 1996:15:47.
  43. M. Pelisse, The vulvo-vaginal-gingival syndrome: a new form of erosive lichen planus, Int J Dermatol 1989:28:381.
  44. H. J. Wallace, Lichen sclerosus et atrophicus, Transactions St. John’s Dermatol Soc 1971:57:9; F. M. Lewis, C. L. Harrington, Squamous cell carcinoma arising in vulval lichen planus, Br J Dermatol 1994:131:703; C. M. Dweyer, R. E. I. Kerr, D. W. M. Millan, Squamous carcinoma following vulvar lichen planus, Arch Dermatol 1098:125:1677; I. Zaki, K. L. Dalziel, F. A. Solomonsz, A. Stevens, The under-reporting of skin disease in association with squamous cell carcinoma of the vulva, Clin Exper Dermatol 1997:21:334.
  45. O. Wiltz, D. J. Schoetz Jr., J. J. Murray, et al., Perianal hidradenitis suppurativa: the Lahey Clinic experience, Dis Colon Rectum 1990:33:731.
  46. C. C. Yu, M. G. Cook, Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands, Br J Dermatol 1990:122:763.
  47. T. J. Brown, T Rosen, I. F. Orengo, Hidradenitis suppurativa, South Med J 1998:91:1107.
  48. J. Lapins, C. Jarstrand, L. Emtestam, Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery, Br J Dermatol 1999:140:90.
  49. A. J. Stellon, M. Wakeling, Hidradenitis suppurativa associated with use of oral contraceptives, BMJ 1989:298:28.
  50. F. Lewis, A. G. Messenger, J. K. Wales, Hidradenitis suppurativa as a presenting feature of premature adrenarche, Br J Dermatol 1993:129:447.
  51. J. H. Barth, A. M. Layton, W. J. Cunliffe, Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa, Br J Dermatol 1996:134:1057.
  52. P. S. Mortimer, R. P. Dawber, M. A. Gales, R. A. Moore, Mediation of hidradenitis suppurativa by androgens, Br Med J (Clin Res Ed) 1986:292:245.
  53. J. S. Fitzsimmons, P. R. Guilbert, E. M. Fitzsimmons, Evidence of genetic factors in hidradenitis suppurativa, Br J Dermatol 1985:113:1.
  54. O. J. Clemmensen, Topical treatment of hidradenitis suppurativa with clindamycin, Int J Dermatol 1983:22:325; G. B. Jemec, P. Wendelboe, Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa, J Am Acad Dermatol 1998:39:971.
  55. T. J. Brown, T. Rosen, I. F. Orengo, Hidradenitis suppurativa, South Med J 1998:91:1107.
  56. M. L. Turner, oral presentation at the XIVth International Congress of the International Society for the Study of Vulvovaginal Disease, Baveno, Italy, September 14–18, 1997.
  57. A. K. Banerjee, Surgical treatment of hidradenitis suppurativa, Br J Surg 1992:79:863.
  58. P. S. Mortimer, R. P. Dawber, M. A. Gales, R. A. Moore, A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa, Br J Dermatol 1986:115:263.
  59. J. Boer, M. J. P. van Gemert, Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa, J Am Acad Dermatol 1999:40:73; G. F. Webster, Acne vulgaris: state of the science [editorial: comment], Arch Dermatol 1999:135:1101.
  60. Boer, van Gemert, Long-term results of isotretinoin.
  61. M. Stegar, Acne inversa, in Dermatology, Progress and Perspectives: The Proceedings of the 18th World Congress of Dermatology, W. H. Burgdorf, S. I. Katz, eds. (New York: Parthenon Publishing Group, 1993), 366.
  62. A. K. Gupta, C. N. Ellis, B. J. Nickoloff, et al., Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses: a clinical and immunopathologic analysis, Arch Dermatol 1990:126:339; D. A. Buckley, S. Rogers, Cyclosporin-responsive hidradenitis suppurativa, J R Soc Med 1995:88:289P.



.

        All rights reserved. Copyright © 2002 - 2010 by Elizabeth G. Stewart, M.D.      Site design: www.gordonwithers.com and www.iilii.net